The Economics of Pandemics: Exploring Globally Shared Experiences
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Cham
Springer International Publishing AG
2022
|
Schlagworte: | |
Online-Zugang: | HWR01 |
Beschreibung: | Description based on publisher supplied metadata and other sources |
Beschreibung: | 1 Online-Ressource (325 Seiten) |
ISBN: | 9783030910211 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV048920937 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 230502s2022 |||| o||u| ||||||eng d | ||
020 | |a 9783030910211 |9 978-3-030-91021-1 | ||
035 | |a (ZDB-30-PQE)EBC6887309 | ||
035 | |a (ZDB-30-PAD)EBC6887309 | ||
035 | |a (ZDB-89-EBL)EBL6887309 | ||
035 | |a (OCoLC)1302010895 | ||
035 | |a (DE-599)BVBBV048920937 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-2070s | ||
082 | 0 | |a 333.7 | |
084 | |a QN 200 |0 (DE-625)141802: |2 rvk | ||
100 | 1 | |a Seo, S. Niggol |e Verfasser |4 aut | |
245 | 1 | 0 | |a The Economics of Pandemics |b Exploring Globally Shared Experiences |
264 | 1 | |a Cham |b Springer International Publishing AG |c 2022 | |
264 | 4 | |c ©2022 | |
300 | |a 1 Online-Ressource (325 Seiten) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Description based on publisher supplied metadata and other sources | ||
505 | 8 | |a Intro -- Preface -- References -- Contents -- About the Author -- List of Figures -- List of Tables -- Chapter 1: The COVID-19 Pandemic as a Globally Shared Experience: An Introduction -- 1 The COVID-19 Pandemic Overwhelms the Planet -- 2 The Novel Coronavirus: SARS-CoV-2 -- 3 The Pandemics in the History of Mankind -- 4 Human and Economic Tolls of the COVID-19 -- 5 Humanitarian Costs of the COVID-19 -- 5.1 Lockdowns -- 5.2 School Closures -- 5.3 Church Services -- 5.4 Domestic Violence, Suicide, and Mental Health -- 6 Race for a Vaccine -- 7 Global Governance: WHO -- 8 Orders and Mandates by National Governments -- 9 A Golden Opportunity for a Radical Social Transformation? -- 10 A Harbinger for a Climate Change Doomsday? -- 11 The Economics of Pandemics -- 12 The Road Ahead -- References -- Chapter 2: Pandemic Economics: Essential Features and Outstanding Questions -- 1 Introduction -- 2 A Pandemic as a Globally Shared Good -- 3 Production Technologies in Pandemics: Weakest Link or Best Shot? -- 3.1 A Cumulative Technology -- 3.2 A Weakest-Link Technology -- 3.3 A Best-Shot Technology -- 4 Market Failures and Governmental Interventions in Pandemic Economics -- 4.1 Failures in Vaccine Developments? -- 4.2 How Much Should a Nation Invest in Pandemic Preparedness and Prevention? -- 4.3 Which Policy Options and Market Responses Are Possible? -- 5 National Health Systems During Pandemics -- 6 The Impacts of the Pandemic on Economy -- 7 Pandemic Policy Choices and Economic Outcomes -- 8 Looking Ahead -- References -- Chapter 3: Pandemic Analysis I: Global Governance for a Global Pandemic? -- 1 Introduction to the Pandemics and Global Governance -- 2 WHO Under the United Nations System -- 3 Key Decisions of the WHO During the COVID-19 Pandemic -- 3.1 Declaring a Human-to-Human Transmission | |
505 | 8 | |a 3.2 Declaring a Public Health Emergency of International Concern -- 3.3 Nomenclature and Declaring a Pandemic -- 3.4 Etiology: Origin of the SARS-CoV-2 -- 3.5 Solidarity Trial for Repurposed Drugs -- 4 National Responses Versus the WHO -- 5 Is a Global Pandemic Treaty Needed? -- 6 Key Conclusions -- References -- Chapter 4: Pandemic Analysis II: Governmental Actions During the Pandemic-Lockdown or No Lockdown? -- 1 Introduction to Governmental Actions During a Pandemic -- 2 A Brief Summary of the Key Decisions by the US Government -- 3 Decision I: Public Health Emergency of International Concern? -- 4 Decision II: Suspend Travels from the Origin? -- 5 Decision III: Social Measures Be Voluntary or Mandated? -- 6 Decision IV: Lockdown, No Lockdown, School Closures -- 7 Decision V: Economic Relief -- 8 Decision VI: Defense Production Act -- 9 Decision VII: Emergency Use Authorizations for Treatments -- 10 Decision VIII: Vaccine Developments -- 11 Final Words: Civil Liberty Versus Protecting Lives -- References -- Chapter 5: Pandemic Analysis III: The Great Reset, People's Uprisings, and Other Radical Change Proposals -- 1 A Government-Aid Economy with No Private Businesses Under the COVID-19 -- 2 Movement I: The Great Reset -- 2.1 A Diagnosis of the Pandemic -- 2.2 The Five-Point Agenda -- 2.3 The Great Reset Agenda -- 2.4 A Critique of the Great Reset Agenda -- 3 Movement II: An Entrepreneurial Government-Led Capitalism -- 4 Movement III: A Marxist Revolution -- 5 Movement IV: A Trigger of the Uprisings and Revolutions by the Most Hurt -- 5.1 The Divergent Economic and Health Impacts of the COVID-19 -- 6 Will They Have Any Impact on Society? -- References -- Chapter 6: Pandemic Analysis IV: Is the COVID-19 Pandemic a Doomsday Scenario for Climate Change? -- 1 A Climate Change Doomsday Scenario | |
505 | 8 | |a 2 The Arguments for the COVID-19 as a Climate Doomsday Scenario -- 3 The Effects of COVID-19 on Climate Change -- 3.1 Global CO2 Emissions -- 3.2 Energy Demands and COVID-19 Policies -- 4 Will Climate Change Cause Pandemics More Frequently or Deadlier Pandemics? -- 5 Final Thoughts -- References -- Chapter 7: Pandemic Analysis V: The Science and Economics of a Vaccine for Ending the Pandemic -- 1 The Miracle of Vaccines -- 2 The Basics of Traditional Vaccines Versus mRNA Vaccines -- 3 Historical Achievements and Failures of Vaccinology -- 4 The Process of Vaccine Developments for COVID-19 -- 4.1 Vaccine Methodologies and Candidate Vaccines -- 4.2 Four Phases of Clinical Trials -- 4.3 An Emergency Use Authorization -- 5 A Partnership Between the Public Sector and the Private Sector: The Operation Warp Speed -- 6 The Economics of Vaccines -- 7 Will the Vaccines End the COVID-19 Pandemic? -- 8 Final Words -- References -- Chapter 8: The Economics of Pandemics as a Globally Shared Experience: A Theory -- 1 Introduction -- 2 The Pandemics as a Globally Shared Good -- 3 The Decision Array by Economic Actors During the Pandemics -- 4 The Four Fault Lines in the Pandemic Risk Management -- 5 The Economics I: A Microbehavioral Decision Framework for the Pandemic Management -- 6 The Economics II: Foresighted Decisions on Pandemics -- 6.1 An Increase in Health Spending -- 6.2 AI-Based Non-contact Technologies -- 6.3 A National Health Insurance System: Private Versus Public -- 7 The Economics III: Technological Developments for a Backstop -- 8 A Society's Optimal Pathway for the Pandemic Risk Management -- 9 What Lies Ahead in Pandemic Economics -- References -- Chapter 9: Some Yet Unresolved Questions and Mysteries About the COVID-19 Pandemic -- 1 Introduction -- 2 Unresolved Question I: The Origin of the Novel Coronavirus | |
505 | 8 | |a 3 Unresolved Question II: Why Have the Richest Nations in the West Suffered the Most? -- 4 Unresolved Question III: Did Southeast Asians Have Antibodies Before the COVID-19 Pandemic? -- 5 Unresolved Question IV: Why Little Effect on Kids and School Children? -- 6 Unresolved Question V: How Accurate Was the COVID-19 Test? -- 7 Final Words in Concluding the Book -- References -- Index | |
650 | 4 | |a Environmental economics | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Seo, S. Niggol |t The Economics of Pandemics |d Cham : Springer International Publishing AG,c2022 |z 9783030910204 |
912 | |a ZDB-30-PQE | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-034185028 | ||
966 | e | |u https://ebookcentral.proquest.com/lib/hwr/detail.action?docID=6887309 |l HWR01 |p ZDB-30-PQE |q HWR_PDA_PQE |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804185102816641024 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Seo, S. Niggol |
author_facet | Seo, S. Niggol |
author_role | aut |
author_sort | Seo, S. Niggol |
author_variant | s n s sn sns |
building | Verbundindex |
bvnumber | BV048920937 |
classification_rvk | QN 200 |
collection | ZDB-30-PQE |
contents | Intro -- Preface -- References -- Contents -- About the Author -- List of Figures -- List of Tables -- Chapter 1: The COVID-19 Pandemic as a Globally Shared Experience: An Introduction -- 1 The COVID-19 Pandemic Overwhelms the Planet -- 2 The Novel Coronavirus: SARS-CoV-2 -- 3 The Pandemics in the History of Mankind -- 4 Human and Economic Tolls of the COVID-19 -- 5 Humanitarian Costs of the COVID-19 -- 5.1 Lockdowns -- 5.2 School Closures -- 5.3 Church Services -- 5.4 Domestic Violence, Suicide, and Mental Health -- 6 Race for a Vaccine -- 7 Global Governance: WHO -- 8 Orders and Mandates by National Governments -- 9 A Golden Opportunity for a Radical Social Transformation? -- 10 A Harbinger for a Climate Change Doomsday? -- 11 The Economics of Pandemics -- 12 The Road Ahead -- References -- Chapter 2: Pandemic Economics: Essential Features and Outstanding Questions -- 1 Introduction -- 2 A Pandemic as a Globally Shared Good -- 3 Production Technologies in Pandemics: Weakest Link or Best Shot? -- 3.1 A Cumulative Technology -- 3.2 A Weakest-Link Technology -- 3.3 A Best-Shot Technology -- 4 Market Failures and Governmental Interventions in Pandemic Economics -- 4.1 Failures in Vaccine Developments? -- 4.2 How Much Should a Nation Invest in Pandemic Preparedness and Prevention? -- 4.3 Which Policy Options and Market Responses Are Possible? -- 5 National Health Systems During Pandemics -- 6 The Impacts of the Pandemic on Economy -- 7 Pandemic Policy Choices and Economic Outcomes -- 8 Looking Ahead -- References -- Chapter 3: Pandemic Analysis I: Global Governance for a Global Pandemic? -- 1 Introduction to the Pandemics and Global Governance -- 2 WHO Under the United Nations System -- 3 Key Decisions of the WHO During the COVID-19 Pandemic -- 3.1 Declaring a Human-to-Human Transmission 3.2 Declaring a Public Health Emergency of International Concern -- 3.3 Nomenclature and Declaring a Pandemic -- 3.4 Etiology: Origin of the SARS-CoV-2 -- 3.5 Solidarity Trial for Repurposed Drugs -- 4 National Responses Versus the WHO -- 5 Is a Global Pandemic Treaty Needed? -- 6 Key Conclusions -- References -- Chapter 4: Pandemic Analysis II: Governmental Actions During the Pandemic-Lockdown or No Lockdown? -- 1 Introduction to Governmental Actions During a Pandemic -- 2 A Brief Summary of the Key Decisions by the US Government -- 3 Decision I: Public Health Emergency of International Concern? -- 4 Decision II: Suspend Travels from the Origin? -- 5 Decision III: Social Measures Be Voluntary or Mandated? -- 6 Decision IV: Lockdown, No Lockdown, School Closures -- 7 Decision V: Economic Relief -- 8 Decision VI: Defense Production Act -- 9 Decision VII: Emergency Use Authorizations for Treatments -- 10 Decision VIII: Vaccine Developments -- 11 Final Words: Civil Liberty Versus Protecting Lives -- References -- Chapter 5: Pandemic Analysis III: The Great Reset, People's Uprisings, and Other Radical Change Proposals -- 1 A Government-Aid Economy with No Private Businesses Under the COVID-19 -- 2 Movement I: The Great Reset -- 2.1 A Diagnosis of the Pandemic -- 2.2 The Five-Point Agenda -- 2.3 The Great Reset Agenda -- 2.4 A Critique of the Great Reset Agenda -- 3 Movement II: An Entrepreneurial Government-Led Capitalism -- 4 Movement III: A Marxist Revolution -- 5 Movement IV: A Trigger of the Uprisings and Revolutions by the Most Hurt -- 5.1 The Divergent Economic and Health Impacts of the COVID-19 -- 6 Will They Have Any Impact on Society? -- References -- Chapter 6: Pandemic Analysis IV: Is the COVID-19 Pandemic a Doomsday Scenario for Climate Change? -- 1 A Climate Change Doomsday Scenario 2 The Arguments for the COVID-19 as a Climate Doomsday Scenario -- 3 The Effects of COVID-19 on Climate Change -- 3.1 Global CO2 Emissions -- 3.2 Energy Demands and COVID-19 Policies -- 4 Will Climate Change Cause Pandemics More Frequently or Deadlier Pandemics? -- 5 Final Thoughts -- References -- Chapter 7: Pandemic Analysis V: The Science and Economics of a Vaccine for Ending the Pandemic -- 1 The Miracle of Vaccines -- 2 The Basics of Traditional Vaccines Versus mRNA Vaccines -- 3 Historical Achievements and Failures of Vaccinology -- 4 The Process of Vaccine Developments for COVID-19 -- 4.1 Vaccine Methodologies and Candidate Vaccines -- 4.2 Four Phases of Clinical Trials -- 4.3 An Emergency Use Authorization -- 5 A Partnership Between the Public Sector and the Private Sector: The Operation Warp Speed -- 6 The Economics of Vaccines -- 7 Will the Vaccines End the COVID-19 Pandemic? -- 8 Final Words -- References -- Chapter 8: The Economics of Pandemics as a Globally Shared Experience: A Theory -- 1 Introduction -- 2 The Pandemics as a Globally Shared Good -- 3 The Decision Array by Economic Actors During the Pandemics -- 4 The Four Fault Lines in the Pandemic Risk Management -- 5 The Economics I: A Microbehavioral Decision Framework for the Pandemic Management -- 6 The Economics II: Foresighted Decisions on Pandemics -- 6.1 An Increase in Health Spending -- 6.2 AI-Based Non-contact Technologies -- 6.3 A National Health Insurance System: Private Versus Public -- 7 The Economics III: Technological Developments for a Backstop -- 8 A Society's Optimal Pathway for the Pandemic Risk Management -- 9 What Lies Ahead in Pandemic Economics -- References -- Chapter 9: Some Yet Unresolved Questions and Mysteries About the COVID-19 Pandemic -- 1 Introduction -- 2 Unresolved Question I: The Origin of the Novel Coronavirus 3 Unresolved Question II: Why Have the Richest Nations in the West Suffered the Most? -- 4 Unresolved Question III: Did Southeast Asians Have Antibodies Before the COVID-19 Pandemic? -- 5 Unresolved Question IV: Why Little Effect on Kids and School Children? -- 6 Unresolved Question V: How Accurate Was the COVID-19 Test? -- 7 Final Words in Concluding the Book -- References -- Index |
ctrlnum | (ZDB-30-PQE)EBC6887309 (ZDB-30-PAD)EBC6887309 (ZDB-89-EBL)EBL6887309 (OCoLC)1302010895 (DE-599)BVBBV048920937 |
dewey-full | 333.7 |
dewey-hundreds | 300 - Social sciences |
dewey-ones | 333 - Economics of land and energy |
dewey-raw | 333.7 |
dewey-search | 333.7 |
dewey-sort | 3333.7 |
dewey-tens | 330 - Economics |
discipline | Wirtschaftswissenschaften |
discipline_str_mv | Wirtschaftswissenschaften |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>07511nmm a2200433zc 4500</leader><controlfield tag="001">BV048920937</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230502s2022 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783030910211</subfield><subfield code="9">978-3-030-91021-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PQE)EBC6887309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC6887309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL6887309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1302010895</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048920937</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-2070s</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">333.7</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QN 200</subfield><subfield code="0">(DE-625)141802:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Seo, S. Niggol</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The Economics of Pandemics</subfield><subfield code="b">Exploring Globally Shared Experiences</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer International Publishing AG</subfield><subfield code="c">2022</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (325 Seiten)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Intro -- Preface -- References -- Contents -- About the Author -- List of Figures -- List of Tables -- Chapter 1: The COVID-19 Pandemic as a Globally Shared Experience: An Introduction -- 1 The COVID-19 Pandemic Overwhelms the Planet -- 2 The Novel Coronavirus: SARS-CoV-2 -- 3 The Pandemics in the History of Mankind -- 4 Human and Economic Tolls of the COVID-19 -- 5 Humanitarian Costs of the COVID-19 -- 5.1 Lockdowns -- 5.2 School Closures -- 5.3 Church Services -- 5.4 Domestic Violence, Suicide, and Mental Health -- 6 Race for a Vaccine -- 7 Global Governance: WHO -- 8 Orders and Mandates by National Governments -- 9 A Golden Opportunity for a Radical Social Transformation? -- 10 A Harbinger for a Climate Change Doomsday? -- 11 The Economics of Pandemics -- 12 The Road Ahead -- References -- Chapter 2: Pandemic Economics: Essential Features and Outstanding Questions -- 1 Introduction -- 2 A Pandemic as a Globally Shared Good -- 3 Production Technologies in Pandemics: Weakest Link or Best Shot? -- 3.1 A Cumulative Technology -- 3.2 A Weakest-Link Technology -- 3.3 A Best-Shot Technology -- 4 Market Failures and Governmental Interventions in Pandemic Economics -- 4.1 Failures in Vaccine Developments? -- 4.2 How Much Should a Nation Invest in Pandemic Preparedness and Prevention? -- 4.3 Which Policy Options and Market Responses Are Possible? -- 5 National Health Systems During Pandemics -- 6 The Impacts of the Pandemic on Economy -- 7 Pandemic Policy Choices and Economic Outcomes -- 8 Looking Ahead -- References -- Chapter 3: Pandemic Analysis I: Global Governance for a Global Pandemic? -- 1 Introduction to the Pandemics and Global Governance -- 2 WHO Under the United Nations System -- 3 Key Decisions of the WHO During the COVID-19 Pandemic -- 3.1 Declaring a Human-to-Human Transmission</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.2 Declaring a Public Health Emergency of International Concern -- 3.3 Nomenclature and Declaring a Pandemic -- 3.4 Etiology: Origin of the SARS-CoV-2 -- 3.5 Solidarity Trial for Repurposed Drugs -- 4 National Responses Versus the WHO -- 5 Is a Global Pandemic Treaty Needed? -- 6 Key Conclusions -- References -- Chapter 4: Pandemic Analysis II: Governmental Actions During the Pandemic-Lockdown or No Lockdown? -- 1 Introduction to Governmental Actions During a Pandemic -- 2 A Brief Summary of the Key Decisions by the US Government -- 3 Decision I: Public Health Emergency of International Concern? -- 4 Decision II: Suspend Travels from the Origin? -- 5 Decision III: Social Measures Be Voluntary or Mandated? -- 6 Decision IV: Lockdown, No Lockdown, School Closures -- 7 Decision V: Economic Relief -- 8 Decision VI: Defense Production Act -- 9 Decision VII: Emergency Use Authorizations for Treatments -- 10 Decision VIII: Vaccine Developments -- 11 Final Words: Civil Liberty Versus Protecting Lives -- References -- Chapter 5: Pandemic Analysis III: The Great Reset, People's Uprisings, and Other Radical Change Proposals -- 1 A Government-Aid Economy with No Private Businesses Under the COVID-19 -- 2 Movement I: The Great Reset -- 2.1 A Diagnosis of the Pandemic -- 2.2 The Five-Point Agenda -- 2.3 The Great Reset Agenda -- 2.4 A Critique of the Great Reset Agenda -- 3 Movement II: An Entrepreneurial Government-Led Capitalism -- 4 Movement III: A Marxist Revolution -- 5 Movement IV: A Trigger of the Uprisings and Revolutions by the Most Hurt -- 5.1 The Divergent Economic and Health Impacts of the COVID-19 -- 6 Will They Have Any Impact on Society? -- References -- Chapter 6: Pandemic Analysis IV: Is the COVID-19 Pandemic a Doomsday Scenario for Climate Change? -- 1 A Climate Change Doomsday Scenario</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">2 The Arguments for the COVID-19 as a Climate Doomsday Scenario -- 3 The Effects of COVID-19 on Climate Change -- 3.1 Global CO2 Emissions -- 3.2 Energy Demands and COVID-19 Policies -- 4 Will Climate Change Cause Pandemics More Frequently or Deadlier Pandemics? -- 5 Final Thoughts -- References -- Chapter 7: Pandemic Analysis V: The Science and Economics of a Vaccine for Ending the Pandemic -- 1 The Miracle of Vaccines -- 2 The Basics of Traditional Vaccines Versus mRNA Vaccines -- 3 Historical Achievements and Failures of Vaccinology -- 4 The Process of Vaccine Developments for COVID-19 -- 4.1 Vaccine Methodologies and Candidate Vaccines -- 4.2 Four Phases of Clinical Trials -- 4.3 An Emergency Use Authorization -- 5 A Partnership Between the Public Sector and the Private Sector: The Operation Warp Speed -- 6 The Economics of Vaccines -- 7 Will the Vaccines End the COVID-19 Pandemic? -- 8 Final Words -- References -- Chapter 8: The Economics of Pandemics as a Globally Shared Experience: A Theory -- 1 Introduction -- 2 The Pandemics as a Globally Shared Good -- 3 The Decision Array by Economic Actors During the Pandemics -- 4 The Four Fault Lines in the Pandemic Risk Management -- 5 The Economics I: A Microbehavioral Decision Framework for the Pandemic Management -- 6 The Economics II: Foresighted Decisions on Pandemics -- 6.1 An Increase in Health Spending -- 6.2 AI-Based Non-contact Technologies -- 6.3 A National Health Insurance System: Private Versus Public -- 7 The Economics III: Technological Developments for a Backstop -- 8 A Society's Optimal Pathway for the Pandemic Risk Management -- 9 What Lies Ahead in Pandemic Economics -- References -- Chapter 9: Some Yet Unresolved Questions and Mysteries About the COVID-19 Pandemic -- 1 Introduction -- 2 Unresolved Question I: The Origin of the Novel Coronavirus</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3 Unresolved Question II: Why Have the Richest Nations in the West Suffered the Most? -- 4 Unresolved Question III: Did Southeast Asians Have Antibodies Before the COVID-19 Pandemic? -- 5 Unresolved Question IV: Why Little Effect on Kids and School Children? -- 6 Unresolved Question V: How Accurate Was the COVID-19 Test? -- 7 Final Words in Concluding the Book -- References -- Index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Environmental economics</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Seo, S. Niggol</subfield><subfield code="t">The Economics of Pandemics</subfield><subfield code="d">Cham : Springer International Publishing AG,c2022</subfield><subfield code="z">9783030910204</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PQE</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034185028</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://ebookcentral.proquest.com/lib/hwr/detail.action?docID=6887309</subfield><subfield code="l">HWR01</subfield><subfield code="p">ZDB-30-PQE</subfield><subfield code="q">HWR_PDA_PQE</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV048920937 |
illustrated | Not Illustrated |
index_date | 2024-07-03T21:55:16Z |
indexdate | 2024-07-10T09:49:54Z |
institution | BVB |
isbn | 9783030910211 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034185028 |
oclc_num | 1302010895 |
open_access_boolean | |
owner | DE-2070s |
owner_facet | DE-2070s |
physical | 1 Online-Ressource (325 Seiten) |
psigel | ZDB-30-PQE ZDB-30-PQE HWR_PDA_PQE |
publishDate | 2022 |
publishDateSearch | 2022 |
publishDateSort | 2022 |
publisher | Springer International Publishing AG |
record_format | marc |
spelling | Seo, S. Niggol Verfasser aut The Economics of Pandemics Exploring Globally Shared Experiences Cham Springer International Publishing AG 2022 ©2022 1 Online-Ressource (325 Seiten) txt rdacontent c rdamedia cr rdacarrier Description based on publisher supplied metadata and other sources Intro -- Preface -- References -- Contents -- About the Author -- List of Figures -- List of Tables -- Chapter 1: The COVID-19 Pandemic as a Globally Shared Experience: An Introduction -- 1 The COVID-19 Pandemic Overwhelms the Planet -- 2 The Novel Coronavirus: SARS-CoV-2 -- 3 The Pandemics in the History of Mankind -- 4 Human and Economic Tolls of the COVID-19 -- 5 Humanitarian Costs of the COVID-19 -- 5.1 Lockdowns -- 5.2 School Closures -- 5.3 Church Services -- 5.4 Domestic Violence, Suicide, and Mental Health -- 6 Race for a Vaccine -- 7 Global Governance: WHO -- 8 Orders and Mandates by National Governments -- 9 A Golden Opportunity for a Radical Social Transformation? -- 10 A Harbinger for a Climate Change Doomsday? -- 11 The Economics of Pandemics -- 12 The Road Ahead -- References -- Chapter 2: Pandemic Economics: Essential Features and Outstanding Questions -- 1 Introduction -- 2 A Pandemic as a Globally Shared Good -- 3 Production Technologies in Pandemics: Weakest Link or Best Shot? -- 3.1 A Cumulative Technology -- 3.2 A Weakest-Link Technology -- 3.3 A Best-Shot Technology -- 4 Market Failures and Governmental Interventions in Pandemic Economics -- 4.1 Failures in Vaccine Developments? -- 4.2 How Much Should a Nation Invest in Pandemic Preparedness and Prevention? -- 4.3 Which Policy Options and Market Responses Are Possible? -- 5 National Health Systems During Pandemics -- 6 The Impacts of the Pandemic on Economy -- 7 Pandemic Policy Choices and Economic Outcomes -- 8 Looking Ahead -- References -- Chapter 3: Pandemic Analysis I: Global Governance for a Global Pandemic? -- 1 Introduction to the Pandemics and Global Governance -- 2 WHO Under the United Nations System -- 3 Key Decisions of the WHO During the COVID-19 Pandemic -- 3.1 Declaring a Human-to-Human Transmission 3.2 Declaring a Public Health Emergency of International Concern -- 3.3 Nomenclature and Declaring a Pandemic -- 3.4 Etiology: Origin of the SARS-CoV-2 -- 3.5 Solidarity Trial for Repurposed Drugs -- 4 National Responses Versus the WHO -- 5 Is a Global Pandemic Treaty Needed? -- 6 Key Conclusions -- References -- Chapter 4: Pandemic Analysis II: Governmental Actions During the Pandemic-Lockdown or No Lockdown? -- 1 Introduction to Governmental Actions During a Pandemic -- 2 A Brief Summary of the Key Decisions by the US Government -- 3 Decision I: Public Health Emergency of International Concern? -- 4 Decision II: Suspend Travels from the Origin? -- 5 Decision III: Social Measures Be Voluntary or Mandated? -- 6 Decision IV: Lockdown, No Lockdown, School Closures -- 7 Decision V: Economic Relief -- 8 Decision VI: Defense Production Act -- 9 Decision VII: Emergency Use Authorizations for Treatments -- 10 Decision VIII: Vaccine Developments -- 11 Final Words: Civil Liberty Versus Protecting Lives -- References -- Chapter 5: Pandemic Analysis III: The Great Reset, People's Uprisings, and Other Radical Change Proposals -- 1 A Government-Aid Economy with No Private Businesses Under the COVID-19 -- 2 Movement I: The Great Reset -- 2.1 A Diagnosis of the Pandemic -- 2.2 The Five-Point Agenda -- 2.3 The Great Reset Agenda -- 2.4 A Critique of the Great Reset Agenda -- 3 Movement II: An Entrepreneurial Government-Led Capitalism -- 4 Movement III: A Marxist Revolution -- 5 Movement IV: A Trigger of the Uprisings and Revolutions by the Most Hurt -- 5.1 The Divergent Economic and Health Impacts of the COVID-19 -- 6 Will They Have Any Impact on Society? -- References -- Chapter 6: Pandemic Analysis IV: Is the COVID-19 Pandemic a Doomsday Scenario for Climate Change? -- 1 A Climate Change Doomsday Scenario 2 The Arguments for the COVID-19 as a Climate Doomsday Scenario -- 3 The Effects of COVID-19 on Climate Change -- 3.1 Global CO2 Emissions -- 3.2 Energy Demands and COVID-19 Policies -- 4 Will Climate Change Cause Pandemics More Frequently or Deadlier Pandemics? -- 5 Final Thoughts -- References -- Chapter 7: Pandemic Analysis V: The Science and Economics of a Vaccine for Ending the Pandemic -- 1 The Miracle of Vaccines -- 2 The Basics of Traditional Vaccines Versus mRNA Vaccines -- 3 Historical Achievements and Failures of Vaccinology -- 4 The Process of Vaccine Developments for COVID-19 -- 4.1 Vaccine Methodologies and Candidate Vaccines -- 4.2 Four Phases of Clinical Trials -- 4.3 An Emergency Use Authorization -- 5 A Partnership Between the Public Sector and the Private Sector: The Operation Warp Speed -- 6 The Economics of Vaccines -- 7 Will the Vaccines End the COVID-19 Pandemic? -- 8 Final Words -- References -- Chapter 8: The Economics of Pandemics as a Globally Shared Experience: A Theory -- 1 Introduction -- 2 The Pandemics as a Globally Shared Good -- 3 The Decision Array by Economic Actors During the Pandemics -- 4 The Four Fault Lines in the Pandemic Risk Management -- 5 The Economics I: A Microbehavioral Decision Framework for the Pandemic Management -- 6 The Economics II: Foresighted Decisions on Pandemics -- 6.1 An Increase in Health Spending -- 6.2 AI-Based Non-contact Technologies -- 6.3 A National Health Insurance System: Private Versus Public -- 7 The Economics III: Technological Developments for a Backstop -- 8 A Society's Optimal Pathway for the Pandemic Risk Management -- 9 What Lies Ahead in Pandemic Economics -- References -- Chapter 9: Some Yet Unresolved Questions and Mysteries About the COVID-19 Pandemic -- 1 Introduction -- 2 Unresolved Question I: The Origin of the Novel Coronavirus 3 Unresolved Question II: Why Have the Richest Nations in the West Suffered the Most? -- 4 Unresolved Question III: Did Southeast Asians Have Antibodies Before the COVID-19 Pandemic? -- 5 Unresolved Question IV: Why Little Effect on Kids and School Children? -- 6 Unresolved Question V: How Accurate Was the COVID-19 Test? -- 7 Final Words in Concluding the Book -- References -- Index Environmental economics Erscheint auch als Druck-Ausgabe Seo, S. Niggol The Economics of Pandemics Cham : Springer International Publishing AG,c2022 9783030910204 |
spellingShingle | Seo, S. Niggol The Economics of Pandemics Exploring Globally Shared Experiences Intro -- Preface -- References -- Contents -- About the Author -- List of Figures -- List of Tables -- Chapter 1: The COVID-19 Pandemic as a Globally Shared Experience: An Introduction -- 1 The COVID-19 Pandemic Overwhelms the Planet -- 2 The Novel Coronavirus: SARS-CoV-2 -- 3 The Pandemics in the History of Mankind -- 4 Human and Economic Tolls of the COVID-19 -- 5 Humanitarian Costs of the COVID-19 -- 5.1 Lockdowns -- 5.2 School Closures -- 5.3 Church Services -- 5.4 Domestic Violence, Suicide, and Mental Health -- 6 Race for a Vaccine -- 7 Global Governance: WHO -- 8 Orders and Mandates by National Governments -- 9 A Golden Opportunity for a Radical Social Transformation? -- 10 A Harbinger for a Climate Change Doomsday? -- 11 The Economics of Pandemics -- 12 The Road Ahead -- References -- Chapter 2: Pandemic Economics: Essential Features and Outstanding Questions -- 1 Introduction -- 2 A Pandemic as a Globally Shared Good -- 3 Production Technologies in Pandemics: Weakest Link or Best Shot? -- 3.1 A Cumulative Technology -- 3.2 A Weakest-Link Technology -- 3.3 A Best-Shot Technology -- 4 Market Failures and Governmental Interventions in Pandemic Economics -- 4.1 Failures in Vaccine Developments? -- 4.2 How Much Should a Nation Invest in Pandemic Preparedness and Prevention? -- 4.3 Which Policy Options and Market Responses Are Possible? -- 5 National Health Systems During Pandemics -- 6 The Impacts of the Pandemic on Economy -- 7 Pandemic Policy Choices and Economic Outcomes -- 8 Looking Ahead -- References -- Chapter 3: Pandemic Analysis I: Global Governance for a Global Pandemic? -- 1 Introduction to the Pandemics and Global Governance -- 2 WHO Under the United Nations System -- 3 Key Decisions of the WHO During the COVID-19 Pandemic -- 3.1 Declaring a Human-to-Human Transmission 3.2 Declaring a Public Health Emergency of International Concern -- 3.3 Nomenclature and Declaring a Pandemic -- 3.4 Etiology: Origin of the SARS-CoV-2 -- 3.5 Solidarity Trial for Repurposed Drugs -- 4 National Responses Versus the WHO -- 5 Is a Global Pandemic Treaty Needed? -- 6 Key Conclusions -- References -- Chapter 4: Pandemic Analysis II: Governmental Actions During the Pandemic-Lockdown or No Lockdown? -- 1 Introduction to Governmental Actions During a Pandemic -- 2 A Brief Summary of the Key Decisions by the US Government -- 3 Decision I: Public Health Emergency of International Concern? -- 4 Decision II: Suspend Travels from the Origin? -- 5 Decision III: Social Measures Be Voluntary or Mandated? -- 6 Decision IV: Lockdown, No Lockdown, School Closures -- 7 Decision V: Economic Relief -- 8 Decision VI: Defense Production Act -- 9 Decision VII: Emergency Use Authorizations for Treatments -- 10 Decision VIII: Vaccine Developments -- 11 Final Words: Civil Liberty Versus Protecting Lives -- References -- Chapter 5: Pandemic Analysis III: The Great Reset, People's Uprisings, and Other Radical Change Proposals -- 1 A Government-Aid Economy with No Private Businesses Under the COVID-19 -- 2 Movement I: The Great Reset -- 2.1 A Diagnosis of the Pandemic -- 2.2 The Five-Point Agenda -- 2.3 The Great Reset Agenda -- 2.4 A Critique of the Great Reset Agenda -- 3 Movement II: An Entrepreneurial Government-Led Capitalism -- 4 Movement III: A Marxist Revolution -- 5 Movement IV: A Trigger of the Uprisings and Revolutions by the Most Hurt -- 5.1 The Divergent Economic and Health Impacts of the COVID-19 -- 6 Will They Have Any Impact on Society? -- References -- Chapter 6: Pandemic Analysis IV: Is the COVID-19 Pandemic a Doomsday Scenario for Climate Change? -- 1 A Climate Change Doomsday Scenario 2 The Arguments for the COVID-19 as a Climate Doomsday Scenario -- 3 The Effects of COVID-19 on Climate Change -- 3.1 Global CO2 Emissions -- 3.2 Energy Demands and COVID-19 Policies -- 4 Will Climate Change Cause Pandemics More Frequently or Deadlier Pandemics? -- 5 Final Thoughts -- References -- Chapter 7: Pandemic Analysis V: The Science and Economics of a Vaccine for Ending the Pandemic -- 1 The Miracle of Vaccines -- 2 The Basics of Traditional Vaccines Versus mRNA Vaccines -- 3 Historical Achievements and Failures of Vaccinology -- 4 The Process of Vaccine Developments for COVID-19 -- 4.1 Vaccine Methodologies and Candidate Vaccines -- 4.2 Four Phases of Clinical Trials -- 4.3 An Emergency Use Authorization -- 5 A Partnership Between the Public Sector and the Private Sector: The Operation Warp Speed -- 6 The Economics of Vaccines -- 7 Will the Vaccines End the COVID-19 Pandemic? -- 8 Final Words -- References -- Chapter 8: The Economics of Pandemics as a Globally Shared Experience: A Theory -- 1 Introduction -- 2 The Pandemics as a Globally Shared Good -- 3 The Decision Array by Economic Actors During the Pandemics -- 4 The Four Fault Lines in the Pandemic Risk Management -- 5 The Economics I: A Microbehavioral Decision Framework for the Pandemic Management -- 6 The Economics II: Foresighted Decisions on Pandemics -- 6.1 An Increase in Health Spending -- 6.2 AI-Based Non-contact Technologies -- 6.3 A National Health Insurance System: Private Versus Public -- 7 The Economics III: Technological Developments for a Backstop -- 8 A Society's Optimal Pathway for the Pandemic Risk Management -- 9 What Lies Ahead in Pandemic Economics -- References -- Chapter 9: Some Yet Unresolved Questions and Mysteries About the COVID-19 Pandemic -- 1 Introduction -- 2 Unresolved Question I: The Origin of the Novel Coronavirus 3 Unresolved Question II: Why Have the Richest Nations in the West Suffered the Most? -- 4 Unresolved Question III: Did Southeast Asians Have Antibodies Before the COVID-19 Pandemic? -- 5 Unresolved Question IV: Why Little Effect on Kids and School Children? -- 6 Unresolved Question V: How Accurate Was the COVID-19 Test? -- 7 Final Words in Concluding the Book -- References -- Index Environmental economics |
title | The Economics of Pandemics Exploring Globally Shared Experiences |
title_auth | The Economics of Pandemics Exploring Globally Shared Experiences |
title_exact_search | The Economics of Pandemics Exploring Globally Shared Experiences |
title_exact_search_txtP | The Economics of Pandemics Exploring Globally Shared Experiences |
title_full | The Economics of Pandemics Exploring Globally Shared Experiences |
title_fullStr | The Economics of Pandemics Exploring Globally Shared Experiences |
title_full_unstemmed | The Economics of Pandemics Exploring Globally Shared Experiences |
title_short | The Economics of Pandemics |
title_sort | the economics of pandemics exploring globally shared experiences |
title_sub | Exploring Globally Shared Experiences |
topic | Environmental economics |
topic_facet | Environmental economics |
work_keys_str_mv | AT seosniggol theeconomicsofpandemicsexploringgloballysharedexperiences |